In today’s pharmaceutical landscape, the push for environmental sustainability and decarbonisation is more critical than ever. With increasing concerns about environmental impact and carbon emissions, pharmaceutical manufacturers face mounting pressure to adopt more environmentally astute practices.
Current trends reveal a growing emphasis on reducing carbon footprint and achieving net zero emissions across the industry. However, navigating the complexities of sustainability regulations and emissions-management presents significant challenges for companies striving to meet ambitious goals. Scope 1, 2 and 3 emissions, are under close scrutiny, with Scope 3 emissions proving to be a major hurdle.
ACG recognises the importance of addressing these challenges, and is committed to leading the way in environmentally sustainable packaging solutions for oral solid-dosage forms.
By joining our webinar, you will:
- Gain insights into key regulations and compliance requirements for achieving net zero targets
- Understand the intricacies of scope 1, 2, and 3 emissions, and their impact on the environment and the pharmaceutical value chain
- Learn how to use SBTi to navigate scope 1 and 2 emissions in pharma manufacturing
- Explore innovative ways to create packaging tailored for increased environmental sustainability in oral solid-dosage forms while maintaining product integrity and quality.
Join us for this informative webinar and take the lead the way in achieving net-zero emissions in pharmaceutical manufacturing.